Millions have died due to COVID-19 infection, and millions more continue experiencing the chronic condition, Long COVID, which makes discovering practical, accessible, and powerful SARS-CoV-2 preventatives and COVID-19 treatments ...
Nov 11, 2022
0
11
Most COVID-19 therapeutics target the SARS-CoV-2 proteins. Because the viral proteins acquire genetic sequence mutations, the emergence of new variants has a risk to make the drugs ineffective.
Oct 31, 2022
0
5
It's hard to imagine a time when "coronavirus" wasn't a household word. But for a long time, this family of viruses had merited very little attention. Believed to be ubiquitous among animals and avian species, the first coronavirus ...
Oct 4, 2022
0
15
Lassa fever is a viral illness that is far too common in West Africa. Although it can have a mortality rate of 15% in severe cases, up to 90% in pregnant women, and causes deafness in a quarter of survivors, there is no vaccine ...
Jul 21, 2022
0
63
An international team of scientists, led by the University of Bristol, has been investigating how the SARS-CoV-2 virus, the coronavirus responsible for the COVID-19 pandemic, manipulates host proteins to penetrate into human ...
Jun 14, 2022
0
59
A new study helps explain how the virus that causes herpes might change during transmission between partners and over time during a long-term infection within a human host, which could have implications for future treatment ...
May 25, 2022
0
70
A team of UC Davis researchers has identified a protein in the cancer cell's nucleus as a critical agent keeping Kaposi's sarcoma-associated herpesvirus (KSHV) dormant and undetected by the body's immune system. The virus, ...
May 11, 2022
0
52
New research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal, (23-26 April), has identified the third day of hospitalization as a tipping point ...
Apr 23, 2022
0
3
A common genetic change is associated with a reduced risk of severe COVID-19 infection, highlighting a potential target for drugs in early treatment.
Feb 10, 2022
0
77
Mutations to the spike protein of the omicron variant are shown to alter how the virus infects cells and reduce its sensitivity to therapeutic and vaccine-elicited antibodies, according to a paper published in Nature. Booster ...
Feb 3, 2022
0
35
